Indian start-up Nugenics Research to commercialise “Elixir” after showing 54% age reversal in animal study.
New young blood plasma research creates a stir
Posted in biotech/medical
Posted in biotech/medical
Indian start-up Nugenics Research to commercialise “Elixir” after showing 54% age reversal in animal study.